HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shinichi Imafuku Selected Research

calcipotriene (calcipotriol)

7/2021Systematic review and practical guidance on the use of topical calcipotriol and topical calcipotriol with betamethasone dipropionate as long-term therapy for mild-to-moderate plaque psoriasis.
4/2016Proactive treatment with calcipotriol reduces recurrence of plaque psoriasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shinichi Imafuku Research Topics

Disease

34Psoriasis (Pustulosis Palmaris et Plantaris)
07/2022 - 03/2006
5Psoriatic Arthritis
02/2022 - 08/2016
4Infections
02/2022 - 01/2013
4Herpes Zoster
01/2021 - 06/2017
4Neoplasms (Cancer)
06/2017 - 11/2007
3Atopic Dermatitis (Atopic Eczema)
01/2019 - 09/2015
2Hypersensitivity (Allergy)
04/2022 - 11/2020
2Hidradenitis Suppurativa
01/2021 - 09/2019
2Miliary Tuberculosis
02/2020 - 06/2013
2Diarrhea
01/2019 - 08/2017
2Nasopharyngitis
01/2019 - 08/2017
2Nausea
01/2019 - 06/2017
2Bowen's Disease (Disease, Bowen)
07/2016 - 11/2007
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2016 - 11/2007
2Skin Diseases (Skin Disease)
07/2014 - 11/2007
2Neurofibroma
10/2013 - 09/2013
2Neurofibromatosis 1 (Neurofibromatosis Type I)
10/2013 - 09/2013
2Dermatomyositis (Dermatopolymyositis)
07/2013 - 01/2004
2Lymphoma (Lymphomas)
08/2012 - 03/2012
1Herpes Labialis (Fever Blister)
02/2022
1Diabetic Foot
01/2022
1Wounds and Injuries (Trauma)
01/2022
1Ulcer
01/2022
1T-Cell Leukemia (Leukemia, T Cell)
11/2021
1Necrosis
06/2021
1Rheumatoid Arthritis
05/2021
1Hematologic Neoplasms (Hematological Malignancy)
01/2021
1Inflammation (Inflammations)
04/2020
1Tuberculosis (Tuberculoses)
02/2020
1Latent Tuberculosis
02/2020
1Urticaria (Hives)
02/2020
1Hypohidrosis
02/2020
1Abscess
09/2019
1Pain (Aches)
09/2019
1Headache (Headaches)
01/2019
1Kaposi Varicelliform Eruption (Eczema Herpeticum)
12/2018
1Exfoliative Dermatitis (Erythroderma)
06/2018
1Hyperuricemia
12/2017
1Gouty Arthritis
12/2017

Drug/Important Bio-Agent (IBA)

7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2021 - 12/2012
6apremilastIBA
07/2022 - 08/2017
5Adalimumab (Humira)FDA Link
01/2021 - 02/2018
4Biological ProductsIBA
03/2022 - 02/2018
4Proteins (Proteins, Gene)FDA Link
07/2014 - 03/2006
3Prostaglandins AIBA
06/2021 - 08/2016
3Immunoglobulins (Immunoglobulin)IBA
06/2021 - 07/2013
3Janus Kinase InhibitorsIBA
05/2021 - 08/2016
3Infliximab (Remicade)FDA Link
03/2020 - 06/2015
3AntibodiesIBA
03/2020 - 07/2013
3Pharmaceutical PreparationsIBA
05/2019 - 04/2015
3secukinumabIBA
02/2018 - 09/2016
3Immunoglobulin G (IgG)IBA
02/2018 - 07/2013
3Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2017 - 01/2004
2Certolizumab PegolFDA Link
01/2022 - 06/2021
2Phosphodiesterase 4 InhibitorsIBA
11/2021 - 08/2017
2calcipotriene (calcipotriol)FDA LinkGeneric
07/2021 - 04/2016
2tildrakizumabIBA
06/2021 - 06/2021
2Monoclonal AntibodiesIBA
06/2021 - 09/2016
2Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2019
2CytokinesIBA
01/2021 - 10/2013
2Interleukin-17 (Interleukin 17)IBA
04/2020 - 07/2017
2InterleukinsIBA
04/2020 - 03/2020
2Interleukin-12 (IL 12)IBA
03/2020 - 02/2020
2Ustekinumab (CNTO 1275)FDA Link
03/2020 - 12/2012
2InterferonsIBA
02/2020 - 06/2013
2Complement System Proteins (Complement)IBA
02/2018 - 06/2017
2EnzymesIBA
06/2017 - 06/2013
2Adrenal Cortex Hormones (Corticosteroids)IBA
04/2016 - 01/2004
2Cholecalciferol (Vitamin D3)FDA Link
09/2013 - 03/2012
1deucravacitinibIBA
07/2022
1TYK2 Kinase (Tyrosine Kinase 2)IBA
07/2022
1MetalsIBA
04/2022
1brodalumabIBA
03/2022
1DNA (Deoxyribonucleic Acid)IBA
02/2022
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
02/2022
1Therapeutic UsesIBA
01/2022
1Vascular Endothelial Growth FactorsIBA
01/2022
1Surface Antigens (Surface Antigen)IBA
11/2021
1betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric
07/2021
1Biological FactorsIBA
06/2021
1baricitinibIBA
05/2021
1Glycoproteins (Glycoprotein)IBA
01/2021
1Subunit VaccinesIBA
01/2021
1Heparin (Liquaemin)FDA LinkGeneric
11/2020
1Isoniazid (Ftivazide)FDA LinkGeneric
02/2020
1Omalizumab (Xolair)FDA Link
02/2020
1Tumor Necrosis Factor InhibitorsIBA
02/2020
1Cholinergic Agents (Cholinergics)IBA
02/2020
1Indicators and Reagents (Reagents)IBA
12/2019
1Immunoglobulin E (IgE)IBA
06/2018
1Uric Acid (Urate)IBA
12/2017
1ixekizumabIBA
11/2017
1DNA Primase (Primase)IBA
11/2017
1Valacyclovir (Valtrex)FDA LinkGeneric
11/2017

Therapy/Procedure

10Therapeutics
02/2022 - 06/2013
3Biological Therapy
02/2022 - 02/2017
1Transplantation
01/2022
1Heterologous Transplantation (Xenotransplantation)
01/2022
1Immunotherapy
04/2020
1Cardiopulmonary Resuscitation (CPR)
02/2018